Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04959266
Title A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca

Advanced Solid Tumor


Adavosertib + Omeprazole

Adavosertib + Rifampin

Adavosertib + Itraconazole

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.